Cyclacel Pharmaceuticals, Inc. earnings per share and revenue

CYCC earnings per share for the last quarter are -0.72 USD whereas the estimation was -1.44 USD which accounts for 49.83% surprise. Company revenue for the same period amounts to 4.00 k USD despite the estimated figure of 30.00 k USD. Estimated earnings per share for the next quarter are -0.56 USD, and revenue is expected to reach 10.00 k USD. Also watch annual changes over time to get a bigger picture of CYCC earnings per share and revenue dynamics.